4AK-16604-31037
4 vaccinations
1 coded response
36 check-ins
0 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 193 / PA
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 1 — Moderna
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-24
- 2021-03-31
-
2021-04-07
Dose 2 — Moderna
- 2021-04-07
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-09
- 2021-04-10
- 2021-04-11
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-04-12
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-04-13
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-14
Health check-in — day 7, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-14
- 2021-05-19
- 2021-07-07
-
2021-12-21
Dose 3 — Moderna
- 2022-02-18
- 2022-04-07
-
2022-09-28
Dose 4 — Pfizer-BioNTech
-
2022-09-29
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Chills, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-04
- 2022-10-05
- 2022-10-12
- 2022-10-26
- 2022-11-02
- 2022-11-09
-
2023-03-29
Survey response — 6 months, dose 4MedDRA: Hypertension, Postpartum state, Thrombosis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-03-29
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2023-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Moderna | |
| 2 | 2021-04-07 | Moderna | |
| 3 | 2021-12-21 | Moderna | No |
| 4 | 2022-09-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-12 | Unsuccessful | |
| 2021-04-13 | Unsuccessful | |
| 2023-03-29 | Unsuccessful |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypertension | · | · | ✓ |
| SD | Postpartum state | · | · | ✓ |
| SD | Thrombosis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release